AAPL $249.94 ▼ 1.69% MSFT $391.79 ▼ 1.91% GOOGL $307.69 ▼ 1.04% NVDA $180.40 ▼ 0.84% META $615.68 ▼ 1.12% TSLA $392.78 ▼ 1.63% AMZN $198.45 ▼ 1.07% AAPL $249.94 ▼ 1.69% MSFT $391.79 ▼ 1.91% GOOGL $307.69 ▼ 1.04% NVDA $180.40 ▼ 0.84% META $615.68 ▼ 1.12% TSLA $392.78 ▼ 1.63% AMZN $198.45 ▼ 1.07%
VAZIAx by Vaziri

Latest News

Artificial Intelligence • Medical • Technology

AI
📅 March 18, 2026

Google DeepMind's AlphaFold 3 Predicts Protein Structures with 99% Accuracy

DeepMind has released AlphaFold 3, achieving near-perfect accuracy in predicting protein structures and drug interactions. The breakthrough is expected to accelerate drug discovery by 10x.

📰 Source: Nature / DeepMind Blog
Medical
📅 March 17, 2026

FDA Approves First CRISPR Gene Therapy for Alzheimer's Disease

The FDA has granted accelerated approval to CRISPR Therapeutics' new treatment. Early clinical trials showed 68% reduction in cognitive decline for early-stage patients.

📰 Source: FDA.gov / Medical News Today
AI
📅 March 16, 2026

OpenAI Unveils GPT-Operator: Autonomous AI Agents for Enterprise

OpenAI launched GPT-Operator, capable of executing complex multi-step tasks independently. The system can book flights, manage spreadsheets, and code entire applications.

📰 Source: OpenAI Blog / TechCrunch
Medical
📅 March 15, 2026

Universal Cancer Vaccine Enters Phase 3 Clinical Trials

BioNTech and Moderna's mRNA-based universal cancer vaccine has entered final testing phases, showing 89% efficacy in Phase 2 against pancreatic and lung cancers.

📰 Source: BioNTech / Lancet Oncology
Tech
📅 March 14, 2026

IBM Integrates Quantum Computing with Neural Networks

IBM announced the first commercially viable quantum-neural hybrid processor. The 1,000+ qubit system solves optimization problems 50,000x faster than classical supercomputers.

📰 Source: IBM Research / MIT Technology Review